Trinity Biotech PLC

TRIB

Company Profile

  • Business description

    Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.

  • Contact

    IDA Business Park
    Bray, County Wicklow
    DublinA98 H5C8
    IRL

    T: +353 12769800

    E: [email protected]

    https://www.trinitybiotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    287

Stocks News & Analysis

stocks

What did Morningstar subscribers buy and sell during June?

ETFs took centre stage in June alongside renewed interest in beaten down growth names.
stocks

Australia’s largest gold miner downgraded on a falling gold price

A cooling gold price sees fair value cuts across the board.
stocks

Cheap ASX share pays a heavy price for NRL rights

Growth has slowed amid increased competition for viewers and content.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,999.001.400.02%
CAC 408,364.6525.690.31%
DAX 4025,114.2547.160.19%
Dow JONES (US)52,498.64138.37-0.26%
FTSE 10010,498.291.000.01%
HKSE24,279.2965.570.27%
NASDAQ25,873.18408.43-1.55%
Nikkei 22567,624.88382.160.57%
NZX 50 Index13,651.2271.98-0.52%
S&P 5007,515.3460.05-0.79%
S&P/ASX 2008,805.902.200.02%
SSE Composite Index3,934.7920.990.54%

Market Movers